UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WITH DIALYS‐DEPENDENT RENAL IMPAIRMENT

Hematological oncology, 2023-06, Vol.41 (S2), p.782-783

2023

Volltextzugriff (PDF)

PB2009: OPPORTUNITIES OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WITH DIALYSIS‐DEPENDENT RENAL IMPAIRMENT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1880-1881

2022

Volltextzugriff (PDF)

Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial

Hematological oncology, 2017-06, Vol.35 (S2), p.62-63

2017

Volltextzugriff (PDF)

A DOUBLE‐BLIND, RANDOMIZED PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT‐P10 TO RITUXIMAB IN COMBINATION WITH CVP IN PATIENTS WITH ADVANCED‐STAGE FOLLICULAR LYMPHOMA

Hematological oncology, 2017-06, Vol.35 (S2), p.218-220

2017

Volltextzugriff (PDF)

Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study

Hematological oncology, 2017-06, Vol.35 (S2), p.210-211

2017

Volltextzugriff (PDF)

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

Leukemia & lymphoma, 2019-12, Vol.60 (14), p.3375-3385

2019

Volltextzugriff (PDF)

Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study

Annals of oncology, 2017-09, Vol.28, p.v355-v355

2017

Volltextzugriff (PDF)

051 “Andrianne mini-jupette” graft at the time of inflatable penile prosthesis placement for the management of post-prostatectomy climacturia and minimal urinary incontinence

Journal of sexual medicine, 2018-07, Vol.15 (7), p.S146-S146

2018

Volltextzugriff (PDF)

Standard of Living of the Population: Economic and Social Indicators of Development

Ėkonomika (Alma Ata, Kazakhstan), 2023-06, Vol.18 (2), p.37-56

2023

Volltextzugriff (PDF)

RETRACTED: Enterprise strategic plan: Service business model

Business strategy & development, 2023-03, Vol.6 (1), p.101-116

2023

Volltextzugriff (PDF)

Enterprise strategic plan: Service business model

Business strategy & development, 2023-03, Vol.6 (1), p.101-116

2023

Volltextzugriff (PDF)

Velcade in multiple myeloma

Terapevtic̆eskii arhiv, 2007, Vol.79 (7), p.70

2007

Volltextzugriff (PDF)

Chromosomal characteristics of malignant lymphoma

Human genetics, 1989-07, Vol.82 (4), p.343-348

1989

Volltextzugriff (PDF)

A phase I-II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 on days 1 and 15 every 28 days in non-Hodgkin or Hodgkin lymphoma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8539-8539

2008

Volltextzugriff (PDF)

A Phase I-II Study To Determine the Safety, Pharmacokinetics and Potential Efficacy of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 on Days 1 and 15 of a 28 Day Schedule in Patients with Non-Hodgkin's or Hodgkin's Lymphoma

Blood, 2007-11, Vol.110 (11), p.2556-2556

2007

Volltextzugriff (PDF)

Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data

Terapevtic̆eskii arhiv, 2011, Vol.83 (7), p.26

2011

Volltextzugriff (PDF)

Primary mediastinal (thymic) large B-cell lymphoma: review of the literature and author's own data

Terapevtic̆eskii arhiv, 2011, Vol.83 (7), p.38

2011

Volltextzugriff (PDF)

Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells

Terapevtic̆eskii arhiv, 2003, Vol.75 (1), p.65

2003

Volltextzugriff (PDF)

Differential diagnosis of B-cell lymphoma rich in T cells and peripheral T-cell lymphomas

Arkhiv patologii, 2000-07, Vol.62 (4), p.8

2000

Volltextzugriff (PDF)

Richter's syndrome: analysis of literature data and original observations

Terapevtic̆eskii arhiv, 1999, Vol.71 (7), p.47

1999

Volltextzugriff (PDF)

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S36-S37

2016

Volltextzugriff (PDF)

The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S28-S28

2015

Volltextzugriff (PDF)

The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas

Terapevtic̆eskii arhiv, 1996, Vol.68 (7), p.42

1996

Volltextzugriff (PDF)

The clinicoimmunological characteristics of blast transformation in lymphosarcomas

Terapevtic̆eskii arhiv, 1994, Vol.66 (7), p.36

1994

Volltextzugriff (PDF)

Global trends in molecular epidemiology of HIV-1 during 2000-2007

AIDS (London), 2011-03, Vol.25 (5), p.679-689

2011

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(195)
Russisch
(48)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WITH DIALYS‐DEPENDENT RENAL IMPAIRMENT

PB2009: OPPORTUNITIES OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WITH DIALYSIS‐DEPENDENT RENAL IMPAIRMENT

Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial

A DOUBLE‐BLIND, RANDOMIZED PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT‐P10 TO RITUXIMAB IN COMBINATION WITH CVP IN PATIENTS WITH ADVANCED‐STAGE FOLLICULAR LYMPHOMA

Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study

051 “Andrianne mini-jupette” graft at the time of inflatable penile prosthesis placement for the management of post-prostatectomy climacturia and minimal urinary incontinence

Standard of Living of the Population: Economic and Social Indicators of Development

RETRACTED: Enterprise strategic plan: Service business model

Enterprise strategic plan: Service business model

Velcade in multiple myeloma

Chromosomal characteristics of malignant lymphoma

A phase I-II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 on days 1 and 15 every 28 days in non-Hodgkin or Hodgkin lymphoma

A Phase I-II Study To Determine the Safety, Pharmacokinetics and Potential Efficacy of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 on Days 1 and 15 of a 28 Day Schedule in Patients with Non-Hodgkin's or Hodgkin's Lymphoma

Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data

Primary mediastinal (thymic) large B-cell lymphoma: review of the literature and author's own data

Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells

Differential diagnosis of B-cell lymphoma rich in T cells and peripheral T-cell lymphomas

Richter's syndrome: analysis of literature data and original observations

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse

The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas

The clinicoimmunological characteristics of blast transformation in lymphosarcomas

Global trends in molecular epidemiology of HIV-1 during 2000-2007

Suchergebnisse filtern